A detailed history of Dynamic Technology Lab Private LTD transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Dynamic Technology Lab Private LTD holds 13,830 shares of RNA stock, worth $438,687. This represents 0.07% of its overall portfolio holdings.

Number of Shares
13,830
Holding current value
$438,687
% of portfolio
0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$29.08 - $52.5 $402,176 - $726,075
13,830 New
13,830 $402,000
Q4 2023

Feb 09, 2024

BUY
$4.87 - $9.37 $137,139 - $263,859
28,160 Added 114.34%
52,788 $478,000
Q3 2023

Nov 14, 2023

BUY
$6.3 - $11.35 $535 - $964
85 Added 0.35%
24,628 $157,000
Q2 2023

Aug 14, 2023

BUY
$10.62 - $17.34 $260,646 - $425,575
24,543 New
24,543 $272,000
Q2 2022

Aug 12, 2022

BUY
$11.18 - $20.5 $181,104 - $332,079
16,199 New
16,199 $235,000

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.65B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.